Increased skeletal muscle capillarization enhances insulin sensitivity

American Journal of Physiology - Endocrinology and Metabolism

Volumn 307, Issue 12, 2014, Pages E1105-E1116

  Akerstrom, Thorbjorn ^a   Laub, Lasse ^a   Vedel, Kenneth ^a   Brand, Christian Lehn ^b   Pedersen, Bente Klarlund ^c   Lindqvist, Anna Kaufmann ^a   Wojtaszewski, Jørgen F P ^a   Hellsten, Ylva ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NOVO NORDISK A S   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DRINKING WATER; GLUCOSE TRANSPORTER 4; PRAZOSIN; PROTEIN KINASE B BETA; TUMOR NECROSIS FACTOR ALPHA; ANTIHYPERTENSIVE AGENT; GLUCOSE; INSULIN;

ADIPOSE TISSUE; ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GLUCOSE TRANSPORT; GLYCOGEN LIVER LEVEL; HYPERINSULINEMIA; INJECTION; INSULIN SENSITIVITY; MUSCLE FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SKELETAL MUSCLE CAPILLARIZATION; SOLEUS MUSCLE; TISSUE SPECIFICITY; ANIMAL; DRUG EFFECTS; GLUCOSE CLAMP TECHNIQUE; INSULIN RESISTANCE; MALE; METABOLISM; MICROCIRCULATION; SPRAGUE DAWLEY RAT; UPREGULATION; VASCULARIZATION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; INSULIN; INSULIN RESISTANCE; MALE; MICROCIRCULATION; MUSCLE, SKELETAL; PRAZOSIN; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

EID: 84918826830     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00020.2014     Document Type: Article

References (56)

1. Akerstrom TC, Krogh-Madsen R, Petersen AM, Pedersen BK. Glucose ingestion during endurance training in men attenuates expression of myokine receptor. Exp Physiol 94: 1124–1131, 2009.
2. Andersson PE, Lithell H. Metabolic effects of doxazosin and enalapril in hypertriglyceridemic, hypertensive men. Relationship to changes in skeletal muscle blood flow. Am J Hypertens 9: 323–333, 1996.
3. Bateman DN, Hobbs DC, Twomey TM, Stevens EA, Rawlins MD. Prazosin, pharmacokinetics and concentration effect. Eur J Clin Pharmacol 16: 177–181, 1979.
4. Baum O, Da Silva-Azevedo L, Willerding G, Wöckel A, Planitzer G, Gossrau R, Pries AR, Zakrzewicz A. Endothelial NOS is main mediator for shear stress-dependent angiogenesis in skeletal muscle after prazosin administration. Am J Physiol Heart Circ Physiol 287: H2300–H2308, 2004.
5. Bonner JS, Lantier L, Hasenour CM, James FD, Bracy DP, Wasserman DH. Muscle-specific vascular endothelial growth factor deletion induces muscle capillary rarefaction creating muscle insulin resistance. Diabetes 62: 572–580, 2013.
6. Borst SE, Lee Y, Conover CF, Shek EW, Bagby GJ. Neutralization of tumor necrosis factor-_ reverses insulin resistance in skeletal muscle but not adipose tissue. Am J Physiol Endocrinol Metab 287: E934–E938, 2004.
7. Chiu JD, Richey JM, Harrison LN, Zuniga E, Kolka CM, Kirkman E, Ellmerer M, Bergman RN. Direct administration of insulin into skeletal muscle reveals that the transport of insulin across the capillary endothelium limits the time course of insulin to activate glucose disposal. Diabetes 57: 828–835, 2008.
8. Clerk LH, Vincent MA, Jahn LA, Liu Z, Lindner JR, Barrett EJ. Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle. Diabetes 55: 1436–1442, 2006.
9. Dall’Aglio E, Chang H, Reaven GM. Disparate effects of prazosin and propranolol on lipid metabolism in a rat model. Am J Med 76: 85–88, 1984.
10. Dawson JM, Hudlicka O. The effects of long term administration of prazosin on the microcirculation in skeletal muscles. Cardiovasc Res 23: 913–920, 1989.
11. Dawson JM, Hudlicka O. Can changes in microcirculation explain capillary growth in skeletal muscle? Int J Exp Pathol 74: 65–71, 1993.
12. Duplain H, Burcelin R, Sartori C, Cook S, Egli M, Lepori M, Vollenweider P, Pedrazzini T, Nicod P, Thorens B, Scherrer U. Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 104: 342–345, 2001.
13. Enevoldsen LH, Stallknecht B, Fluckey JD, Galbo H. Effect of exercise training on in vivo insulin-stimulated glucose uptake in intra-abdominal adipose tissue in rats. Am J Physiol Endocrinol Metab 278: E25–E34, 2000.
14. Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA. Effect of fatty acids on glucose production and utilization in man. J Clin Invest 72: 1737–1747, 1983.
15. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, De-Fronzo RA. beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 90: 493–500, 2005.
16. Friedrichsen M, Mortensen B, Pehmoller C, Birk JB, Wojtaszewski JF. Exercise-induced AMPK activity in skeletal muscle: role in glucose uptake and insulin sensitivity. Mol Cell Endocrinol 366: 204–214, 2013.
17. Frosig C, Rose AJ, Treebak JT, Kiens B, Richter EA, Wojtaszewski JF. Effects of endurance exercise training on insulin signaling in human skeletal muscle: interactions at the level of phosphatidylinositol 3-kinase, Akt, and AS160. Diabetes 56: 2093–2102, 2007.
18. Fukuzawa M, Satoh J, Ohta S, Takahashi K, Miyaguchi S, Qiang X, Sakata Y, Nakazawa T, Takizawa Y, Toyota T. Modulation of tumor necrosis factor-alpha production with anti-hypertensive drugs. Immunopharmacology 48: 65–74, 2000.
19. Gavin TP, Stallings HW 3rd, Zwetsloot KA, Westerkamp LM, Ryan NA, Moore RA, Pofahl WE, Hickner RC. Lower capillary density but no difference in VEGF expression in obese vs. lean young skeletal muscle in humans. J Appl Physiol 98: 315–321, 2005.
20. Giorda C, Appendino M, Mason MG, Imperiale E, Pagano G. Alpha 1-blocker doxazosin improves peripheral insulin sensitivity in diabetic hypertensive patients. Metabolism 44: 673–676, 1995.
21. Hedman A, Byberg L, Reneland R, Lithell HO. Muscle morphology, self-reported physical activity and insulin resistance syndrome. Acta Physiol Scand 175: 325–332, 2002.
22. Højlund K, Mustard KJ, Staehr P, Hardie DG, Beck-Nielsen H, Richter EA, Wojtaszewski JF. AMPK activity and isoform protein expression are similar in muscle of obese subjects with and without type 2 diabetes. Am J Physiol Endocrinol Metab 286: E239–E244, 2004.
23. Holmäng A, Mimura K, Björntorp P, Lönnroth P. Interstitial muscle insulin and glucose levels in normal and insulin-resistant Zucker rats. Diabetes 46: 1799–1804, 1997.
24. James DE, Jenkins AB, Kraegen EW. Heterogeneity of insulin action in individual muscles in vivo: euglycemic clamp studies in rats. Am J Physiol Endocrinol Metab 248: E567–E574, 1985.
25. Keeton TK, Biediger AM. The differential effects of prazosin and hydralazine on sympathoadrenal activity in conscious rats. Eur J Pharmacol 164: 479–486, 1989.
26. Krotkiewski M. Physical training in the prophylaxis and treatment of obesity, hypertension and diabetes. Scand J Rehabil Med Suppl 9: 55–70, 1983.
27. Kubota T, Kubota N, Kumagai H, Yamaguchi S, Kozono H, Takahashi T, Inoue M, Itoh S, Takamoto I, Sasako T, Kumagai K, Kawai T, Hashimoto S, Kobayashi T, Sato M, Tokuyama K, Nishimura S, Tsunoda M, Ide T, Murakami K, Yamazaki T, Ezaki O, Kawamura K, Masuda H, Moroi M, Sugi K, Oike Y, Shimokawa H, Yanagihara N, Tsutsui M, Terauchi Y, Tobe K, Nagai R, Kamata K, Inoue K, Kodama T, Ueki K, Kadowaki T. Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle. Cell Metab 13: 294–307, 2011.
28. Lillioja S, Young AA, Culter CL, Ivy JL, Abbott WG, Zawadzki JK, Yki-Jarvinen H, Christin L, Secomb TW, Bogardus C. Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 80: 415–424, 1987.
29. Mandroukas K, Krotkiewski M, Hedberg M, Wroblewski Z, Bjorntorp P, Grimby G. Physical training in obese women. Effects of muscle morphology, biochemistry and function. Eur J Appl Physiol Occup Physiol 52: 355–361, 1984.
30. Marin P, Andersson B, Krotkiewski M, Bjorntorp P. Muscle fiber composition and capillary density in women and men with NIDDM. Diabetes Care 17: 382–386, 1994.
31. Michel CC, Curry FE. Microvascular permeability. Physiol Rev 79: 703–761, 1999.
32. Miles PD, Levisetti M, Reichart D, Khoursheed M, Moossa AR, Olefsky JM. Kinetics of insulin action in vivo. Identification of ratelimiting steps. Diabetes 44: 947–953, 1995.
33. Mulvihill-Wilson J, Gaffney FA, Pettinger WA, Blomqvist CG, Anderson S, Graham RM. Hemodynamic and neuroendocrine responses to acute and chronic alpha-adrenergic blockade with prazosin and phenoxybenzamine. Circulation 67: 383–393, 1983.
34. Passonneau JV, Lauderdale VR. A comparison of three methods of glycogen measurement in tissues. Anal Biochem 60: 405–412, 1974.
35. Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK. Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 54: 2939–2945, 2005.
36. Pollare T, Lithell H, Selinus I, Berne C. Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension. Diabetologia 31: 415–420, 1988.
37. Regittnig W, Ellmerer M, Fauler G, Sendlhofer G, Trajanoski Z, Leis HJ, Schaupp L, Wach P, Pieber TR. Assessment of transcapillary glucose exchange in human skeletal muscle and adipose tissue. Am J Physiol Endocrinol Metab 285: E241–E251, 2003.
38. Sansbury BE, Cummins TD, Tang Y, Hellmann J, Holden CR, Harbeson MA, Chen Y, Patel RP, Spite M, Bhatnagar A, Hill BG. Overexpression of endothelial nitric oxide synthase prevents diet-induced obesity and regulates adipocyte phenotype. Circ Res 111: 1176–1189, 2012.
39. Shankar RR, Wu Y, Shen HQ, Zhu JS, Baron AD. Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes 49: 684–687, 2000.
40. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 106: 171–176, 2000.
41. Sjöstrand M, Gudbjörnsdottir S, Holmäng A, Lönn L, Strindberg L, Lönnroth P. Delayed transcapillary transport of insulin to muscle interstitial fluid in obese subjects. Diabetes 51: 2742–2748, 2002.
42. Sjöstrand M, Holmäng A, Strindberg L, Lönnroth P. Estimations of muscle interstitial insulin, glucose, and lactate in type 2 diabetic subjects. Am J Physiol Endocrinol Metab 279: E1097–E1103, 2000.
43. Smith D, Rossetti L, Ferrannini E, Johnson CM, Cobelli C, Toffolo G, Katz LD, DeFronzo RA. In vivo glucose metabolism in the awake rat: tracer and insulin clamp studies. Metabolism 36: 1167–1174, 1987.
44. Solomon TP, Haus JM, Li Y, Kirwan JP. Progressive hyperglycemia across the glucose tolerance continuum in older obese adults is related to skeletal muscle capillarization and nitric oxide bioavailability. J Clin Endocrinol Metab 96: 1377–1384, 2011.
45. Thong FS, Bilan PJ, Klip A. The Rab GTPase-activating protein AS160 integrates Akt, protein kinase C, and AMP-activated protein kinase signals regulating GLUT4 traffic. Diabetes 56: 414–423, 2007.
46. Treebak JT, Taylor EB, Witczak CA, An D, Toyoda T, Koh HJ, Xie J, Feener EP, Wojtaszewski JF, Hirshman MF, Goodyear LJ. Identification of a novel phosphorylation site on TBC1D4 regulated by AMPactivated protein kinase in skeletal muscle. Am J Physiol Cell Physiol 298: C377–C385, 2010.
47. Van Gieson EJ, Skalak TC. Chronic vasodilation induces matrix metalloproteinase 9 (MMP-9) expression during microvascular remodeling in rat skeletal muscle. Microcirculation 8: 25–31, 2001.
48. Vincent MA, Barrett EJ, Lindner JR, Clark MG, Rattigan S. Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am J Physiol Endocrinol Metab 285: E123–E129, 2003.
49. Vincent MA, Clerk LH, Lindner JR, Klibanov AL, Clark MG, Rattigan S, Barrett EJ. Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo. Diabetes 53: 1418–1423, 2004.
50. Williams JL, Cartland D, Rudge JS, Egginton S. VEGF trap abolishes shear stress- and overload-dependent angiogenesis in skeletal muscle. Microcirculation 13: 499–509, 2006.
51. Wojtaszewski JF, Hansen BF, Gade, Kiens B, Markuns JF, Goodyear LJ, Richter EA. Insulin signaling and insulin sensitivity after exercise in human skeletal muscle. Diabetes 49: 325–331, 2000.
52. Youd JM, Rattigan S, Clark MG. Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNF-alpha. Diabetes 49: 1904–1909, 2000.
53. Yu J, Tyml K. Capillary adrenoceptors in rat skeletal muscle. Microvasc Res 53: 235–244, 1997.
54. Zhang L, Vincent MA, Richards SM, Clerk LH, Rattigan S, Clark MG, Barrett EJ. Insulin sensitivity of muscle capillary recruitment in vivo. Diabetes 53: 447–453, 2004.
55. Zhou A, Egginton S, Hudlicka O, Brown MD. Internal division of capillaries in rat skeletal muscle in response to chronic vasodilator treatment with alpha1-antagonist prazosin. Cell Tissue Res 293: 293–303, 1998.
56. Ziada A, Hudlicka O, Tyler KR. The effect of long-term administration of alpha 1-blocker prazosin on capillary density in cardiac and skeletal muscle. Pflugers Arch 415: 355–360, 1989.